Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Colchicine vs CoQ10: CoQ10 has the stronger overall evidence (8 vs 3/10); they're alternatives for support heart health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
CoQ10 wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Likely helps
9 of 10 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Colchicine and CoQ10 have evidence — compare verdict strength side-by-side.
Off-label cardiovascular/geroprotective use is low-dose: 0.5 mg once daily (the regimen in the cited LoDoCo and COLCOT trials) under a clinician. Acute gout uses higher short-course dosing. Not an approved longevity regimen; mind the drug interactions.
Any time of day
Low-dose oral tablet (0.5 mg/day)
100-300mg daily
With fatty meal
Ubiquinol (reduced form)
Months to years
Weeks
Trial endpoints
Throughout use
4-12 weeks
8-12 weeks
4-8 weeks
2-8 weeks
Low-dose colchicine for secondary prevention of cardiovascular disease.
Journal of the American College of Cardiology (2013) · Rct · n=532
LoDoCo randomized trial of low-dose colchicine in stable coronary disease
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
The New England journal of medicine (2019) · Rct
COLCOT randomized, placebo-controlled trial of colchicine 0.5 mg/day after MI
Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
Heart, lung & circulation (2022) · Meta analysis
Meta-analysis of colchicine trials for secondary cardiovascular prevention
Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Reproductive sciences (Thousand Oaks, Calif.) (2023) · Meta analysis · n=1021
Meta-analysis of 9 randomised trials with 1,021 women with polycystic ovary syndrome.
Coenzyme Q10 for heart failure
The Cochrane database of systematic reviews (2021) · Meta analysis · n=1573
Coenzyme Q10 probably reduces the risk of all-cause mortality more than control (RR 0.58, 95% CI 0.35 to 0.95; 1 study, 420 participants; number needed to treat for an additional beneficial outcome (NNTB) 13.3; moderate-quality evidence).
Antioxidants for female subfertility
The Cochrane database of systematic reviews (2017) · Meta analysis · n=6510
This suggests that among subfertile women with an expected clinical pregnancy rate of 22%, the rate among women using antioxidants would be between 27% and 33%.
CoQ10 has a higher evidence score (8/10 vs 3/10) and wins in 2 of 3 categories.
For support heart health, CoQ10 has a higher relevance score (80 vs 58).
No known interactions between Colchicine and CoQ10 have been documented in our database. However, always consult a healthcare provider before combining supplements.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
Tired? Why most "energy" pills only work if they fix a deficit — and how to find yours first.
Magnesium, riboflavin, CoQ10 — the supplements with real migraine-prevention evidence (and doses).
CoQ10, zinc, selenium, carnitine modestly help sperm parameters — but live-birth evidence is weak.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.